Dr. Andrey Molchanov is the Director of Pharmacovigilance and Business Development in Western Europe. He holds a PhD in Pharmaceutical Chemistry from the Free University of Berlin/Germany. He has been in the Clinical Trials sector since 2012, and is heavily involved with  Regulatory Affairs and Pharmacovigilance in the European Union, where he held the position of Head of Pharmacovigilance. Andrey’s expertise lies in Drug Safety Strategy, Pharmacovigilance, Regulatory Affairs for the EU and Business Development.